Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer

已完结 10 由达姆发布于 2026/5/7 15:51:07

DOI:10.1016/j.annonc.2025.11.002
作者：L. Cabel ,?F. Berger ,?T. Bachelot ,?B. Pistilli ,?F. Dalenc ,?T. de la Motte Rouge ,?R. Sabatier ,?A. Lortholary ,?S. Marques ,?J. Vibert ,?S. Renault ,?A.C. Hardy-Bessard ,?S. Delaloge ,?A. Pradines
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundPADA-1 was the first prospective randomized trial to show that early therapeutic targeting of blood ESR1 mutations (bESR1-mut) with fulvestrant provides significant clinical benefi

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for Cancer Research (AACR)Returning to PARP inhibition: Rechallenge with Bevacizumab in Ovarian Cancer.